Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization

Journal of the American College of Cardiology

Volumn 31, Issue 5, 1998, Pages 1018-1026

  Schwarz, Ernst R ^c   Schoendube, Friedrich A ^d   Kostin, Sawa ^a   Schmiedtke, Nicole ^d   Schulz, Gernot ^d   Buell, Udalrich ^d   Messmer, Bruno J ^d   Morrison, John ^b   Hanrath, Peter ^d   Vom Dahl, Juergen ^d  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL DEGENERATION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; MYOCARDIUM; POSTOPERATIVE PERIOD; TIME FACTORS;

EID: 0032054232     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00041-2     Document Type: Article

References (37)

1. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72:123-35.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
3. Rahimtoola SH. From coronary artery disease to heart failure: role of the hibernating myocardium. Am J Cardiol 1995;75:16E-22E.
4. De Servi S, Eleuteri E, Bramucci E, et al. Effects of coronary angioplasty on left ventricular function. Am J Cardiol 1993;72:119G-123G.
5. Cohen M, Charney R, Hershman R, Fuster V, Gorlin R. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol 1988;12:1193-8.
6. Nienaber CA, Bruncken RC, Sherman CT, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18:966-78.
7. Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971;284:1116-20.
8. Chatterjee K, Swan HJC, Parmley WW, et al. Influence of direct revascularization on the left ventricular asynergy and function in patients with coronary heart disease. Circulation 1973;47:276-86.
9. Brundage BH, Massie BM, Botvinick EH, et al. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol 1984;3:902-8.
10. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron emission tomography. N Engl J Med 1986;314:884-8.
11. Bonow RO, Dilsizian V. Assessing viable myocardium with thallium-201. Am J Cardiol 1992;70:10E-17E.
12. Pierard LA, DeLandsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15: 1021-31.
13. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
14. Eitzman D, al Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
15. Topol EJ, Weiss JL, Guzman PA, et al. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. J Am Coll Cardiol 1984;4:1123-34.
16. Vanoverschelde JL, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
17. Schwarz ER, Schaper J, vom Dahl J, et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 1996;27:1577-85.
18. Borgers M, Thone F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary stenosis: chronic hibernation? Cardiovasc Pathol 1993;2: 237-45.
19. Ausma J, Cleutjens J, Thone F, Flameng W, Ramaekers F, Borgers M. Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem 1995;147:35-42.
20. Ausma J, Furst D, Thone F, et al. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation. J Mol Cell Cardiol 1995;27:1203-12.
21. Flameng W, Vanhaecke J, Borgers M. Histology of the postischaemic myocardium and its relation to left ventricular function. Br J Anaesth 1988;60:14S-22S.
22. Depre C, Vanoverschelde JL, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-75.
23. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994; 90:735-45.
24. Schulz R, Rose J, Martin C, Brodde OE, Heusch G. Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation 1993;88:684-95.
25. Dodge HT, Sandler H, Baxley WA, Hawley RR. Usefulness and limitations of radiographic methods for determining left ventricular volumes. Am J Cardiol 1966;18:10-24.
26. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305.
27. Altehoefer C, vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994;35:569-574.
28. vom Dahl J, Altehoefer C, Sheehan FH, et al. Recovery of regional left ventricular dysfunction after coronary revascularization: impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996;28:948-58.
29. Altehoefer C, vom Dahl J, Buell U, Uebis R, Kleinhans E, Hanrath P. Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease. Eur J Nucl Med 1994;21:37-45.
30. Weibel E. Practical Methods for Biological Morphometry, Vol. 1. New York: Academic Press, 1979.
31. Scholz D, Diener W, Schaper J. Altered nucleus/cytoplasm relationship and structural changes in human dilated cardiomyopathy. Cardioscience 1994;5: 127-38.
32. Shivalkar B, Maes A, Borgers M, et al. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation 1996;94:308-15.
33. Borgers M, Ausma J. Structural aspects of the chronic hibernating myocardium in man. Basic Res Cardiol 1995;90:44-6.
34. Celermaier DS, Sholler GF, Howman-Giles R, Celermaier JM. Myocardial infarction in childhood: clinical analysis of 17 cases and medium term follow up of survivors. Br Heart J 1991;65:332-6.
35. Shivalkar B, Borgers M, Daenen W, Gewillig M, Flameng W. ALCAPA syndrome: an example of chronic myocardial hypoperfusion? J Am Coll Cardiol 1994;23:772-8.
36. Ito BR. Gradual onset of myocardial ischemia results in reduced myocardial infarction: association with reduced contractile function and metabolic downregulation. Circulation 1995;91:2058-70.
37. Paolini G, Lucignani G, Zuccari M, et al. Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction. Eur J Cardiothorac Surg 1994;8:139-44.